Table 7.
Geographic distribution of CHL morphologic subtypes.*
| NS | MC | LD | LR | |||||||||
| Region | F | M | S/T | F | M | S/T | F | M | S/T | F | M | S/T |
| N | 9 | 23 | 32 | 4 | 6 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| NE | 43 | 55 | 98 | 9 | 19 | 28 | 1 | 2 | 3 | 0 | 2 | 2 |
| CW | 16 | 15 | 31 | 2 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| S | 28 | 22 | 50 | 3 | 9 | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
| SE | 76 | 74 | 150 | 3 | 35 | 38 | 0 | 0 | 0 | 2 | 1 | 3 |
| T | 172 | 189 | 361 | 21 | 71 | 92 | 1 | 2 | 3 | 2 | 3 | 5 |
*
15 unclassified cases are not included in the table. NS: nodular sclerosis; MC: mixed cellularity; LD: lymphocyte depletion; LR: lymphocyte rich; M: male; F: female; S/T: subtotal of each subgroup; T: total; N: North; NE: Northeast; CW: Central‐West; S: South; SE: Southeast.